|
FDA approves Spiriva Respimat for asthma in adults, adolescents
Healio “The [FDA] approval of Spiriva Respimat in asthma establishes a new class of inhaled asthma therapy and provides an efficacious, new option for patients,” William Mezzanotte, MD, MPH, said in the release. “There is extensive clinical evidence … |
View full post on asthma – Google News